Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will present novel clinical and preclinical data on the mode of action of its lead clinical program...

Related Keywords

Stockholm ,Sweden ,Nijmegen ,Gelderland ,Netherlands ,Italy ,Loosdrecht ,Utrecht ,United States ,Milan ,Lombardia ,American ,Corey Davis ,Jorn Kaspers ,Hans Nijman ,Alex Karlsson Parra ,Haoxiao Zuo ,Mario Brkulj ,Erik Manting ,Gerty Schreibelt ,Satwinder Kaur Singh ,American Society Of Hematology ,Lifesci Advisors ,Radboud Institute For Molecular Life Sciences ,Department Of Tumor Immunology ,Valency Communications ,Radboud University Medical Centre ,International Cancer Immunotherapy Conference ,Acute Myeloid Leukemia ,Jeroen Rovers ,Chief Medical Officer ,Tumor Immunology ,Radboud Institute ,Molecular Life Sciences ,American Society ,Marco De Bruyn ,Jolanda De Vries ,Satwinder Kaur ,Nasdaq Stockholm ,Sci Advisors ,Markets ,